Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Isra Presisi Indonesia Tbk. (ISAP) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Isra Presisi Indonesia Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Isra Presisi Indonesia Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Isra Presisi Indonesia Tbk. trades at Rp27 (market cap 112.57B, 68.52M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 6.1× Isra Presisi Indonesia Tbk.'s market cap, and Isra Presisi Indonesia Tbk. is more actively traded (68.52M versus 635.5K). Which is the better fit depends on your goals.

ISAPLABS
Market Cap
112.57B691.25B
Volume
68.52M635.5K
Lot
685.23K6.36K
Turnover
1.86B110.15M
Average Price
27.16173.33
Value
1.86B110.15M
Indicative Equilibrium Price
27174
Indicative Equilibrium Volume
13.68K50

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ISAP
View details
LABS
View details

About Isra Presisi Indonesia Tbk.

PT Isra Presisi Indonesia Tbk ("The Company") was established on October 22, 2011 based on Notary Deed No. 47 of Evi Nursamsiyati, S.H. The Company started its commercial operations in2011.

Read more on ISAP

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS